The Anemia Control Program: High or Low Iron Supplementation
The Anemia Control Program: High or Low Iron Supplementation
The purpose of this clinical trial was to determine if high-iron or low-iron formula,
 containing an average of 12.7 mg/L or 2.3 mg/L respectively, had differing effects on iron
 status in infancy and on development longitudinally.
For a detailed description of the clinical trial setting and procedures in infancy, please
 refer to the following:

 Walter T, Pino P, Pizarro F and Lozoff B. Prevention of iron-deficiency anemia: Comparison of
 high- and low-iron formulas in term healthy infants after six months of life. J Pedr
 1998:132:635-40.
Inclusion Criteria:

 -  Birth weight >= 3.0 kg

 -  single birth

 -  no major congenital anomalies

 -  no major birth or neonatal complications

 -  no emergency c-section

 -  no jaundice requiring phototherapy

 -  no hospitalization for more than 5 days

 -  no chronic illness

 -  no iron therapy

 -  already started to received some bottle feedings by 6 months of age

 Exclusion Criteria:

 -  residence outside identified neighborhoods

 -  another infant <12 months in household

 -  infant in daycare

 -  unstable, illiterate, or psychotic caregiver